Fatty acid metabolism, enoyl-[acyl-carrier-] reductase
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 8 |
GO:0110165 | cellular anatomical entity | 1 | 8 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pescher et al. (upgregulation) | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: A0A3Q8IE60
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 8 |
GO:0004497 | monooxygenase activity | 3 | 8 |
GO:0016491 | oxidoreductase activity | 2 | 8 |
GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | 3 | 8 |
GO:0016703 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases) | 4 | 8 |
GO:0018580 | nitronate monooxygenase activity | 5 | 8 |
GO:0051213 | dioxygenase activity | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 159 | 161 | PF00675 | 0.341 |
CLV_NRD_NRD_1 | 244 | 246 | PF00675 | 0.260 |
CLV_NRD_NRD_1 | 57 | 59 | PF00675 | 0.341 |
CLV_PCSK_KEX2_1 | 212 | 214 | PF00082 | 0.251 |
CLV_PCSK_KEX2_1 | 244 | 246 | PF00082 | 0.292 |
CLV_PCSK_KEX2_1 | 57 | 59 | PF00082 | 0.341 |
CLV_PCSK_PC1ET2_1 | 212 | 214 | PF00082 | 0.251 |
CLV_PCSK_SKI1_1 | 121 | 125 | PF00082 | 0.260 |
CLV_PCSK_SKI1_1 | 160 | 164 | PF00082 | 0.269 |
CLV_PCSK_SKI1_1 | 233 | 237 | PF00082 | 0.260 |
CLV_PCSK_SKI1_1 | 267 | 271 | PF00082 | 0.296 |
CLV_PCSK_SKI1_1 | 300 | 304 | PF00082 | 0.251 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.432 |
DOC_MAPK_gen_1 | 64 | 71 | PF00069 | 0.341 |
DOC_MAPK_MEF2A_6 | 160 | 169 | PF00069 | 0.260 |
DOC_MAPK_MEF2A_6 | 64 | 73 | PF00069 | 0.264 |
DOC_SPAK_OSR1_1 | 197 | 201 | PF12202 | 0.341 |
DOC_USP7_UBL2_3 | 121 | 125 | PF12436 | 0.260 |
DOC_USP7_UBL2_3 | 253 | 257 | PF12436 | 0.298 |
DOC_USP7_UBL2_3 | 262 | 266 | PF12436 | 0.267 |
DOC_USP7_UBL2_3 | 60 | 64 | PF12436 | 0.264 |
DOC_WW_Pin1_4 | 95 | 100 | PF00397 | 0.260 |
LIG_14-3-3_CanoR_1 | 5 | 10 | PF00244 | 0.296 |
LIG_BRCT_BRCA1_1 | 45 | 49 | PF00533 | 0.246 |
LIG_CaM_IQ_9 | 189 | 204 | PF13499 | 0.260 |
LIG_FHA_1 | 101 | 107 | PF00498 | 0.276 |
LIG_FHA_1 | 150 | 156 | PF00498 | 0.260 |
LIG_FHA_2 | 273 | 279 | PF00498 | 0.301 |
LIG_FHA_2 | 291 | 297 | PF00498 | 0.189 |
LIG_LIR_Gen_1 | 221 | 231 | PF02991 | 0.289 |
LIG_LIR_Gen_1 | 46 | 56 | PF02991 | 0.246 |
LIG_LIR_Nem_3 | 221 | 226 | PF02991 | 0.289 |
LIG_LIR_Nem_3 | 46 | 52 | PF02991 | 0.246 |
LIG_LYPXL_yS_3 | 14 | 17 | PF13949 | 0.260 |
LIG_SH2_STAT5 | 223 | 226 | PF00017 | 0.274 |
LIG_SH3_3 | 162 | 168 | PF00018 | 0.256 |
LIG_SH3_3 | 66 | 72 | PF00018 | 0.230 |
LIG_SH3_3 | 9 | 15 | PF00018 | 0.400 |
LIG_TRAF2_1 | 206 | 209 | PF00917 | 0.251 |
LIG_TYR_ITIM | 12 | 17 | PF00017 | 0.260 |
MOD_CDK_SPK_2 | 95 | 100 | PF00069 | 0.260 |
MOD_CK1_1 | 249 | 255 | PF00069 | 0.290 |
MOD_CK1_1 | 31 | 37 | PF00069 | 0.260 |
MOD_CK1_1 | 95 | 101 | PF00069 | 0.260 |
MOD_CK2_1 | 202 | 208 | PF00069 | 0.260 |
MOD_CK2_1 | 272 | 278 | PF00069 | 0.412 |
MOD_CK2_1 | 290 | 296 | PF00069 | 0.194 |
MOD_GlcNHglycan | 176 | 179 | PF01048 | 0.273 |
MOD_GlcNHglycan | 203 | 207 | PF01048 | 0.261 |
MOD_GlcNHglycan | 24 | 27 | PF01048 | 0.389 |
MOD_GlcNHglycan | 248 | 251 | PF01048 | 0.292 |
MOD_GlcNHglycan | 285 | 288 | PF01048 | 0.230 |
MOD_GlcNHglycan | 30 | 33 | PF01048 | 0.287 |
MOD_GlcNHglycan | 94 | 97 | PF01048 | 0.260 |
MOD_GSK3_1 | 198 | 205 | PF00069 | 0.260 |
MOD_GSK3_1 | 91 | 98 | PF00069 | 0.275 |
MOD_NEK2_1 | 246 | 251 | PF00069 | 0.262 |
MOD_PIKK_1 | 100 | 106 | PF00454 | 0.260 |
MOD_PIKK_1 | 198 | 204 | PF00454 | 0.341 |
MOD_PKA_1 | 212 | 218 | PF00069 | 0.319 |
MOD_PKA_1 | 244 | 250 | PF00069 | 0.341 |
MOD_PKA_2 | 212 | 218 | PF00069 | 0.319 |
MOD_PKA_2 | 244 | 250 | PF00069 | 0.341 |
MOD_PKA_2 | 4 | 10 | PF00069 | 0.219 |
MOD_Plk_1 | 148 | 154 | PF00069 | 0.260 |
MOD_Plk_4 | 219 | 225 | PF00069 | 0.260 |
MOD_Plk_4 | 5 | 11 | PF00069 | 0.274 |
MOD_ProDKin_1 | 95 | 101 | PF00069 | 0.260 |
MOD_SUMO_for_1 | 124 | 127 | PF00179 | 0.260 |
MOD_SUMO_rev_2 | 82 | 90 | PF00179 | 0.260 |
TRG_DiLeu_BaEn_3 | 86 | 92 | PF01217 | 0.341 |
TRG_DiLeu_BaLyEn_6 | 165 | 170 | PF01217 | 0.260 |
TRG_ENDOCYTIC_2 | 14 | 17 | PF00928 | 0.260 |
TRG_ENDOCYTIC_2 | 223 | 226 | PF00928 | 0.274 |
TRG_ENDOCYTIC_2 | 80 | 83 | PF00928 | 0.274 |
TRG_ER_diArg_1 | 244 | 246 | PF00400 | 0.260 |
TRG_ER_diArg_1 | 305 | 308 | PF00400 | 0.399 |
TRG_ER_diArg_1 | 56 | 58 | PF00400 | 0.341 |
TRG_Pf-PMV_PEXEL_1 | 244 | 248 | PF00026 | 0.239 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IKE9 | Leptomonas seymouri | 81% | 100% |
A4HAH1 | Leishmania braziliensis | 86% | 100% |
A4HBY5 | Leishmania braziliensis | 86% | 100% |
A4I9N1 | Leishmania infantum | 100% | 100% |
A5IR97 | Staphylococcus aureus (strain JH9) | 32% | 89% |
A6QFD2 | Staphylococcus aureus (strain Newman) | 31% | 89% |
A6U025 | Staphylococcus aureus (strain JH1) | 32% | 89% |
A8Z1H7 | Staphylococcus aureus (strain USA300 / TCH1516) | 31% | 89% |
B2TEK6 | Paraburkholderia phytofirmans (strain DSM 17436 / LMG 22146 / PsJN) | 33% | 87% |
D0V3Y4 | Pseudomonas sp. | 33% | 91% |
E9B4N0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
O05413 | Bacillus subtilis (strain 168) | 31% | 91% |
O06179 | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) | 30% | 85% |
P71847 | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) | 30% | 89% |
Q01284 | Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) | 26% | 84% |
Q0S7Q1 | Rhodococcus jostii (strain RHA1) | 30% | 90% |
Q2FIF3 | Staphylococcus aureus (strain USA300) | 31% | 89% |
Q2FZX9 | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 31% | 89% |
Q49W60 | Staphylococcus saprophyticus subsp. saprophyticus (strain ATCC 15305 / DSM 20229 / NCIMB 8711 / NCTC 7292 / S-41) | 34% | 89% |
Q4L4T4 | Staphylococcus haemolyticus (strain JCSC1435) | 31% | 89% |
Q4Q3E6 | Leishmania major | 97% | 100% |
Q5HHG4 | Staphylococcus aureus (strain COL) | 31% | 89% |
Q6GB05 | Staphylococcus aureus (strain MSSA476) | 32% | 89% |
Q6GIG7 | Staphylococcus aureus (strain MRSA252) | 32% | 89% |
Q8NXG7 | Staphylococcus aureus (strain MW2) | 31% | 89% |
Q99VF6 | Staphylococcus aureus (strain N315) | 32% | 89% |
Q9HWH9 | Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) | 32% | 90% |
Q9I4V0 | Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) | 34% | 97% |